108
Participants
Start Date
May 31, 2000
Primary Completion Date
January 3, 2003
Study Completion Date
January 3, 2003
Lanreotide (Autogel formulation)
Semmelweiss University Medical School, Budapest
Semmelweiss University, Budapest
Academic Hospital Leiden, Leiden
Academic Hospital Rotterdam, Rotterdam
New York University Medical Center, New York
Universitätklinikum Charité, Berlin
University of Pennsylvania, Philadelphia
Johns Hopkins University School of Medicine, Baltimore
Baptist Health System Inc, Birmingham
Med. Klinik der Universitätat Essen, Essen
University of Cincinnati, Cincinnati
University of Michigan Medical Center, Ann Arbor
CHRU de Brabois, Vandœuvre-lès-Nancy
Clinique Marc Linquette, Lille
Northwestern Medical Facility, Chicago
Hôpital Lariboisière - Service de Médecine B, Paris
Hôpital Cochin - Service d'Endocrinologie, Paris
Ben Taub Hospital, Houston
Medizinische Klinik Innenstadt, München
Pituitary Center, Los Angeles
Oregon Health Sciences University, Portland
Massachusetts General Hospital, Boston
St Ann's Faculty Hospital, Brno
Queen Mary Hospital, Pokfulam
University Hospital Charles University, Hradec Králové
Charles University, Prague
Queen Elizabeth Hospital, Edgbaston
The Royal Free Hospital, Hampstead
Christie Hospital, Manchester
Lead Sponsor
Ipsen
INDUSTRY